Sionna Therapeutics (SION) Liabilities and Shareholders Equity (2024 - 2026)
Quarterly results put Liabilities and Shareholders Equity at $305.0 million for Q1 2026, down 17.48% from a year ago — trailing twelve months through Mar 2026 was $1.3 billion (up 138.07% YoY), and the annual figure for FY2025 was $326.0 million, up 75.48%.
Sionna Therapeutics has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $305.0 million for Q1 2026.
- Liabilities and Shareholders Equity reached $305.0 million in Q1 2026 per SION's latest filing, down from $326.0 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $369.7 million in Q1 2025 and bottomed at $185.8 million in Q4 2024.
- Median Liabilities and Shareholders Equity over the past 3 years was $332.6 million (2025), compared with a mean of $313.0 million.
- The largest annual shift saw Liabilities and Shareholders Equity soared 75.48% in 2025 before it dropped 17.48% in 2026.
- Over 3 years, Liabilities and Shareholders Equity stood at $185.8 million in 2024, then skyrocketed by 75.48% to $326.0 million in 2025, then decreased by 6.42% to $305.0 million in 2026.
- Business Quant data shows Liabilities and Shareholders Equity for SION at $305.0 million in Q1 2026, $326.0 million in Q4 2025, and $339.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 40.87 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 23.64 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 305.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.04 Mn |
| Dec 31, 2025 | 325.95 Mn |
| Sep 30, 2025 | 339.27 Mn |
| Jun 30, 2025 | 352.05 Mn |
| Mar 31, 2025 | 369.67 Mn |
| Dec 31, 2024 | 185.75 Mn |